Glycans in Diseases and Therapeutics

Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited.

  • Glycomedicine
  • Transfusion medicine
  • Congenital disorders of glycosylation (CDG)
  • Cancer biomarkers
  • Cardiovascular diseases
  • Cardiac arrest
  • Cancer associated coagulopathies

Related Conference of Glycans in Diseases and Therapeutics

April 30-30, 2021

2nd International Conference on Nucleic Acids

London, UK
May 17-18, 2021

11th World Glycobiology Congress

Vienna, Austria
July 26-27, 2021

5th International Conference on Bioscience and Biotechnology

London, Aland Islands
March 15-16, 2021

12th Tissue Repair and Regeneration Congress

Dubai, UAE
July 30-30, 2021

Glycobiology Biochem Conference 2021

London, UK
August 17-18, 2021

23rd Global Biotechnology Congress

Rome, Italy
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland
December 01-02, 2021

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 03-04, 2021

International Conference on Biotechnology

Singapore, Singapore

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in